Testing the efficacy of drugs targeting these molecules in cell lines and animal models. Conducting phase I, II, and III clinical trials to assess safety, efficacy, and optimal dosing in humans. Monitoring for adverse effects and overall survival rates to ensure the target's clinical relevance.
